International Clinical Trial: a Prospective, Multicenter, Randomized Controlled Trial, With a Non-randomized Sentinel Cohort, Evaluating the Efficacy of Bioxheal, a Single-layer Placental-derived Biologic in Nonhealing Diabetic Foot Ulcers

Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07852338) titled 'a Prospective, Multicenter, Randomized Controlled Trial, With a Non-randomized Sentinel Cohort, Evaluating the Efficacy of Bioxheal, a Single-layer Placental-derived Biologic in Nonhealing Diabetic Foot Ulcers' on Sept. 25.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Applied Biologics, LLC

Condition: Diabetic Foot Ulcer Amniotic Membrane Placental Allograft Biologic

Intervention: Biological: All sentinel cohort participants will receive biologic plus SOC. who receive at least o...